EU to support novel antibiotics with €20 million funding
BioVersys will receive €20 million in funding to support its…
BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
List view / Grid view
BioVersys will receive €20 million in funding to support its…
BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
The European Commision (EC) has announced €80 million of support…
The European Commision (EC) has announced €80 million of support to aid in the R&D and production of a COVID-19 coronavirus vaccine.